Clinical Pharmacology of the Reversible and Potent P2Y
12
Receptor Antagonist ACT‐246475 After Single Subcutaneous Administration in Healthy Male Subjects
2018 ◽
Vol 59
(1)
◽
pp. 123-130
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 60
(7)
◽
pp. 931-941
◽
2009 ◽
Vol 49
(10)
◽
pp. 1168-1175
◽
Keyword(s):
2018 ◽
Vol 37
(1)
◽
pp. 139-146
◽
Keyword(s):
2011 ◽
Vol 51
(7)
◽
pp. 1116-1121
◽